Adalat® in the Asian Pacific Region

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Adalat® in the Asian Pacific Region by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

More books from Springer Berlin Heidelberg

Cover of the book Biodegradable Metals by
Cover of the book Negative Co-Receptors and Ligands by
Cover of the book Turbine Blade Investment Casting Die Technology by
Cover of the book Natural and Artificial Rockslide Dams by
Cover of the book Der medizinisch nicht indizierte Eingriff zur kognitiven Leistungssteigerung aus rechtlicher Sicht by
Cover of the book Foundations of Software Science and Computation Structures by
Cover of the book Energieeffizienz in der Industrie by
Cover of the book Minimalinvasive Viszeralchirurgie by
Cover of the book Ribonucleases by
Cover of the book Organisationale Resilienz by
Cover of the book Bone Transplantation by
Cover of the book RNA and Cancer by
Cover of the book Funktionsabhängige Beschwerdebilder des Bewegungssystems by
Cover of the book Virus-Resistant Transgenic Plants: Potential Ecological Impact by
Cover of the book Delikts- und Schadensersatzrecht by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy